Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Май 4, 2021
Bacterial
therapeutics
are
the
emergent
alternatives
in
treating
autoimmune
diseases
such
as
Rheumatoid
Arthritis
[RA].
P.
histicola
MCI
001
is
one
therapeutic
bacterium
that
has
been
proven
to
treat
RA
and
multiple
sclerosis
[MS]
animal
models.
The
present
study
characterized
isolated
from
a
human
duodenal
biopsy,
evaluated
its
impact
on
gut
microbial
metabolic
profile
longitudinal
using
collagen-induced
arthritis
model
HLA-DQ8.AEo
transgenic
mice.
though
closely
related
type
strain
of
,
DSM
19854,
differed
utilizing
glycerol.
In
culture,
produced
vitamins
biotin
folate,
was
involved
digesting
complex
carbohydrates
production
acetate.
Colonization
showed
duodenum
predominant
niche
for
gavaged
001.
A
follow-up
arthritic
mice
treated
with
suggested
dysbiosis
caused
due
partially
restored
naïve
after
treatment.
taxon-level
analysis
an
expansion
intestinal
genus
Allobaculum
MCI001
Eubiosis
achieved
post
treatment
also
reflected
increased
short-chain
fatty
acids
[SCFAs].
Present
suggests
leads
by
increasing
availability
simple
Restoration
metabolites
like
butyrate
induce
immune
homeostasis.
Gut,
Год журнала:
2019,
Номер
68(6), С. 1108 - 1114
Опубликована: Янв. 22, 2019
The
host-microbiome
supraorganism
appears
to
have
coevolved
and
the
unperturbed
microbial
component
of
dyad
renders
host
health
sustainable.
This
coevolution
has
likely
shaped
evolving
phenotypes
in
all
life
forms
on
this
predominantly
planet.
microbiota
seems
exert
effects
next
generation
from
gestation,
via
maternal
immune
responses.
ecosystems
develop,
restricted
their
epithelial
niches
by
system,
concomitantly
with
chronological
development,
providing
early
modulation
physiological
development
functions
for
nutrition,
immunity
resistance
pathogens
at
ages.
Here,
we
review
role
microbiome
human
including
evolutionary
considerations,
maternal/fetal
relationships,
contributions
nutrition
growth.
We
also
discuss
what
constitutes
a
healthy
microbiota,
how
antimicrobial
modern
practices
are
impacting
associations
between
perturbations,
responses
diseases
rocketing
urban
societies
potential
future
restoration.
Nutrients,
Год журнала:
2019,
Номер
11(7), С. 1591 - 1591
Опубликована: Июль 13, 2019
Preserving
the
efficacy
of
probiotic
bacteria
exhibits
paramount
challenges
that
need
to
be
addressed
during
development
functional
food
products.
Several
factors
have
been
claimed
responsible
for
reducing
viability
probiotics
including
matrix
acidity,
level
oxygen
in
products,
presence
other
lactic
acid
bacteria,
and
sensitivity
metabolites
produced
by
competing
bacteria.
approaches
are
undertaken
improve
sustain
microbial
cell
viability,
like
strain
selection,
immobilization
technologies,
synbiotics
etc.
Among
them,
various
carriers,
composite
carrier
systems
has
recently
attracted
interest
targeting
protect
from
different
types
environmental
stress
(e.g.,
pH
heat
treatments).
Likewise,
successfully
deliver
large
intestine,
cells
must
survive
processing
storage,
withstand
conditions
encountered
upper
gastrointestinal
tract.
Hence,
appropriate
selection
their
effective
delivery
remains
a
technological
challenge
with
special
focus
on
sustaining
culture
formulated
product.
Development
synbiotic
combinations
another
approach
stimulate
growth
probiotics.
The
aim
current
review
is
summarize
strategies
novel
techniques
adopted
enhance
Frontiers in Nutrition,
Год журнала:
2021,
Номер
8
Опубликована: Июнь 28, 2021
The
genome
of
gut
microbes
encodes
a
collection
enzymes
whose
metabolic
functions
contribute
to
the
bioavailability
and
bioactivity
unabsorbed
(poly)phenols.
Datasets
from
high
throughput
sequencing,
metabolome
measurements,
other
omics
have
expanded
understanding
different
modes
actions
by
which
(poly)phenols
modulate
microbiome
conferring
health
benefits
host.
Progress
been
made
identify
direct
prebiotic
effects
(poly)phenols;
albeit
up
date,
these
compounds
are
not
recognized
as
prebiotics
sensu
stricto
.
Interestingly,
certain
probiotics
strains
an
enzymatic
repertoire,
such
tannase,
α-L-rhamnosidase,
phenolic
acid
reductase,
involved
in
transformation
into
bioactive
metabolites.
In
vivo
studies
demonstrated
that
(poly)phenol-transforming
bacteria
thrive
when
provided
with
substrates.
However,
taxonomically
distinct
symbionts
phenolic-metabolizing
activity
has
still
significantly
promoted
This
is
case
Akkermansia
muciniphila
,
so-called
antiobesity
bacterium,
responds
positively
may
be
partially
responsible
for
formerly
attributed
molecules.
We
surmise
broad
antimicrobial
action
free
ecological
niches
occupied
competing
bacteria,
thereby
allowing
bloom
beneficial
bacteria.
review
explores
capacity
promote
through
their
collaborative
bacterial
utilization
inhibitory
on
potential
pathogenic
species.
propose
term
duplibiotic
describe
substrate
modulating
microbiota
both
action.
(Poly)phenol
effect
could
participate
blunting
disturbance
dysbiosis,
positioning
dietary
strategies
therapeutic
potential.
Antioxidants,
Год журнала:
2021,
Номер
10(2), С. 188 - 188
Опубликована: Янв. 28, 2021
This
review
presents
the
comprehensive
knowledge
about
bidirectional
relationship
between
polyphenols
and
gut
microbiome.
The
first
part
is
related
to
polyphenols’
impacts
on
various
microorganisms,
especially
bacteria,
their
influence
intestinal
pathogens.
research
data
mechanisms
of
polyphenol
action
were
collected
together
organized.
impact
groups
bacteria
both
whole
“microbiota”
particular
species,
including
probiotics,
are
presented.
Moreover,
present
in
food
(bound
matrix)
was
compared
with
purified
(such
as
dietary
supplements)
well
form
derivatives
glycosides)
those
aglycones.
second
paper
discusses
detail
(pathways)
role
bacterial
biotransformation
most
important
polyphenols,
production
bioactive
metabolites
a
significant
human
organism
(both
positive
negative).
Parkinson's
disease
(PD)
is
a
systemic
clinically
defined
by
the
degeneration
of
dopaminergic
neurons
in
brain.
While
alterations
gut
microbiome
composition
have
been
reported
PD,
their
functional
consequences
remain
unclear.
Herein,
we
addressed
this
question
an
analysis
stool
samples
from
Luxembourg
Study
(n
=
147
typical
PD
cases,
n
162
controls).All
individuals
underwent
detailed
clinical
assessment,
including
neurological
examinations
and
neuropsychological
tests
followed
self-reporting
questionnaires.
Stool
these
were
first
analysed
16S
rRNA
gene
sequencing.
Second,
predicted
potential
secretion
for
129
microbial
metabolites
through
personalised
metabolic
modelling
using
data
genome-scale
reconstructions
human
microbes.
Our
key
results
include
following.
Eight
genera
seven
species
changed
significantly
relative
abundances
between
patients
healthy
controls.
PD-associated
patterns
statistically
depended
on
sex,
age,
BMI,
constipation.
Particularly,
Bilophila
Paraprevotella
associated
with
Hoehn
Yahr
staging
after
controlling
duration.
Furthermore,
microbiomes
revealed
nine
increased
methionine
cysteinylglycine.
The
pantothenic
acid
production
was
linked
to
presence
specific
non-motor
symptoms.Our
suggest
that
can
translate
into
substantial
differences
affecting
host
metabolism
phenotype.
iScience,
Год журнала:
2020,
Номер
23(6), С. 101199 - 101199
Опубликована: Май 23, 2020
The
human
gut
microbiome
is
a
complex
ecosystem
that
both
affects
and
affected
by
its
host
status.
Previous
metagenomic
analyses
of
microflora
revealed
associations
between
specific
microbes
age.
Nonetheless
there
was
no
reliable
way
to
tell
host's
age
based
on
the
community
composition.
Here
we
developed
method
predicting
hosts'
taxonomic
profiles
using
cross-study
dataset
deep
learning.
Our
best
model
has
an
architecture
neural
network
achieves
mean
absolute
error
5.91
years
when
tested
external
data.
We
further
advance
procedure
for
inferring
role
particular
during
aging
defining
them
as
potential
biomarkers.
described
intestinal
clock
represents
unique
quantitative
provides
starting
point
building
succession
into
single
narrative.
Experimental & Molecular Medicine,
Год журнала:
2021,
Номер
53(5), С. 772 - 787
Опубликована: Май 1, 2021
Abstract
Ulcerative
colitis
(UC)
is
a
chronic
recurrent
intestinal
inflammatory
disease
characterized
by
high
incidence
and
young
onset
age.
Recently,
there
have
been
some
interesting
findings
in
the
pathogenesis
of
UC.
The
mucus
barrier,
which
composed
mucin
complex
rich
O-glycosylation,
not
only
provides
nutrients
habitat
for
microbes
but
also
orchestrates
taming
germs.
In
turn,
gut
microbiota
modulates
production
secretion
mucins
stratification
layers.
Active
bidirectional
communication
between
its
‘slimy’
partner,
seems
to
be
continually
performed
concerto,
maintaining
homeostasis
ecological
microenvironment.
Any
abnormalities
may
induce
disorder
community,
thereby
causing
damage.
Our
review
mainly
focuses
on
complicated
barrier
microbiome
explore
promising
new
avenue
UC
therapy.
Toxicological Sciences,
Год журнала:
2020,
Номер
176(2), С. 253 - 284
Опубликована: Май 5, 2020
Abstract
Since
the
surge
of
microbiome
research
in
last
decade,
many
studies
have
provided
insight
into
causes
and
consequences
changes
gut
microbiota.
Among
multiple
factors
involved
regulating
microbiome,
exogenous
such
as
diet
environmental
chemicals
been
shown
to
alter
significantly.
Although
substantially
contributes
are
major
contaminants
our
food
often
overlooked.
Herein,
we
summarize
current
knowledge
on
classes
(bisphenols,
phthalates,
persistent
organic
pollutants,
heavy
metals,
pesticides)
their
impact
which
includes
alterations
microbial
composition,
gene
expression,
function,
health
effects
host.
We
then
discuss
health-related
implications
changes,
include
metabolism,
immunity,
neurological
function.